Articles related to ANTICOAGULANTS

The analysis demonstrates that periprocedural bleeding rates with factor XI inhibition were comparable to or lower than traditional anticoagulation, with only 0.9% of procedures within 30 days of abelacimab dosing experiencing major bleeding complications.

Rates of major bleeding for therapeutic-dose apixaban and dabigatran were similar to those for low-dose aspirin, whereas rates were higher for rivaroxaban.

Antiphospholipid syndrome (APS) is associated with a characteristic netlike ‘livedo’ rash, which can be further classified into livedo reticularis and livedo racemosa.

A fixed 5000 IU heparin dose achieved consistent RAO prevention across all weight groups, with rates ranging from 1.9% to 3.0%, suggesting potential benefits of standardized protocols.

The LAA’s role as the predominant site for thrombus formation in AFib patients positions LAAO as a significant therapeutic approach for stroke prevention.

The 2024 guideline introduces a more nuanced approach to preoperative stress testing and anticoagulation management, potentially reducing unnecessary testing and complications.